Related Experiment Video
Updated: Jun 12, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2
Xinhua Liang1, Yankun Li1, Peng Wang2
1Affiliated Hospital of Guangdong Medical University, Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases, Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Institute of Nephrology, Zhanjiang, Guangdong Province, China.
Insights
Vascular calcification in chronic kidney disease is driven by high phosphate, BMP2, and RUNX2, causing smooth muscle cell changes. Understanding these factors is key to improving patient outcomes and treatment strategies.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Cell Biology
Background:
- Vascular calcification is prevalent in end-stage chronic kidney disease (CKD), significantly increasing cardiovascular morbidity and mortality.
- Osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs) is a critical mechanism underlying vascular calcification in CKD.
- Key molecular players including high phosphate, bone morphogenetic protein 2 (BMP2), and runt-related transcription factor 2 (RUNX2) are implicated in this process.
Purpose of the Study:
- To review the molecular mechanisms by which high phosphate, BMP2, and RUNX2 regulate vascular calcification in CKD.
- To discuss the intricate interactions among these factors and their influence on the progression of vascular calcification.
- To provide insights for future research on VSMC phenotypic switching and osteogenic transdifferentiation, and to inform clinical treatment strategies.
Main Methods:
- Literature review focusing on molecular mechanisms of vascular calcification in CKD.
- Analysis of the roles of high phosphate, BMP2, and RUNX2 in VSMC osteogenic transdifferentiation.
- Synthesis of information on the interactions between these factors and their impact on calcification progression.
Main Results:
- High phosphate, BMP2, and RUNX2 are crucial regulators of VSMC osteogenic transdifferentiation.
- These factors interact in complex ways to drive vascular calcification.
- Understanding these molecular pathways is essential for comprehending CKD-associated cardiovascular complications.
Conclusions:
- Targeting the molecular pathways involving high phosphate, BMP2, and RUNX2 may offer therapeutic strategies for vascular calcification in CKD.
- Further research into VSMC phenotypic switching is warranted to develop effective treatments.
- This review highlights the clinical and scientific importance of understanding these mechanisms for improving CKD patient prognosis.
Abstract:
Vascular calcification is quite common in patients with end-stage chronic kidney disease and is a major trigger for cardiovascular complications in these patients. These complications significantly impact the survival rate and long-term prognosis of individuals with chronic kidney disease. Numerous studies have demonstrated that the development of vascular calcification involves various pathophysiological mechanisms, with the osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs) being of utmost importance. High phosphate levels, bone morphogenetic protein 2 (BMP2), and runt-related transcription factor 2 (RUNX2) play crucial roles in the osteogenic transdifferentiation process of VSMCs. This article primarily reviews the molecular mechanisms by which high phosphate, BMP2, and RUNX2 regulate vascular calcification secondary to chronic kidney disease, and discusses the complex interactions among these factors and their impact on the progression of vascular calcification. The insights provided here aim to offer new perspectives for future research on the phenotypic switching and osteogenic transdifferentiation of VSMCs, as well as to aid in optimizing clinical treatment strategies for this condition, bearing significant clinical and scientific implications.
Related Concept Videos
Skeleton and Calcium Homeostasis
Osteoclasts in Bone Remodeling
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hypertension and Regulation of Blood Pressure
Regulation of Angiogenesis and Blood Supply

